Effects of imipramine on the expression and development of morphine dependence in mice

• Published in: European journal of pharmacology Vol. 473; no. 1; pp. 19 - 25
• Main Authors: Zarrindast, Mohammad-Reza, Torkaman-Boutorabi, Anahita
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier B.V 18-07-2003; Elsevier
• Subjects: Adrenergic alpha-Agonists - administration & dosage; Adrenergic alpha-Agonists - pharmacology; Adrenergic alpha-Antagonists - administration & dosage; Adrenergic alpha-Antagonists - pharmacology; Adrenergic Uptake Inhibitors - administration & dosage; Adrenergic Uptake Inhibitors - pharmacology; Adrenoceptor agent; Animals; Biological and medical sciences; Clonidine - administration & dosage; Clonidine - pharmacology; Dose-Response Relationship, Drug; Imipramine; Imipramine - administration & dosage; Imipramine - pharmacology; Injections, Subcutaneous; Jumping; Male; Medical sciences; Mice; Morphine; Morphine - pharmacology; Morphine Dependence - psychology; Motor Activity - drug effects; Mouse; Naloxone; Phenylephrine - administration & dosage; Phenylephrine - pharmacology; Prazosin - administration & dosage; Prazosin - pharmacology; Receptors, Adrenergic, alpha-1 - drug effects; Receptors, Adrenergic, alpha-2 - drug effects; Yohimbine - administration & dosage; Yohimbine - pharmacology; Imipramine; Morphine; Naloxone; Mouse; Jumping; Adrenoceptor agent
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/S0014-2999(03)01913-7

In the present study, the effects of imipramine and/or α-adrenoceptor agents on naloxone-induced jumping in morphine-dependent mice were examined. In the first set of experiments, the drugs were used before naloxone injection, to test their effects on the expression of jumping. Administration of imipramine (10–60 mg/kg) 15 min before naloxone increased the number of jumping in mice. Injection of the α
2-adrenoceptor agonist, clonidine (0.1 mg/kg), or α
1-adrenoceptor agonist, phenylephrine (4 mg/kg), themselves neither altered naloxone-induced jumping nor influenced the imipramine response. The α
2-adrenoceptor antagonist, yohimbine (4 mg/kg), itself but not the α
1-adrenoceptor antagonist, prazosin (1 mg/kg), increased jumping and decreased the imipramine effect.
In the second set of experiments, imipramine and/or the α-adrenoceptor drugs were injected during the development of morphine dependence. Imipramine (10–40 mg/kg) increased the development of dependence and increased jumping was seen. Clonidine did not influence the imipramine effect. Phenylephrine was lethal in combination with imipramine. Both yohimbine and prazosin decreased the effect of imipramine. Imipramine and phenylephrine but not clonidine, yohimbine or prazosin decreased locomotion. It is concluded an α
2-adrenoceptor mechanism may be involved in the influence of imipramine on the expression and development of naloxone-induced withdrawal signs in mice.